| Health / Medical Topics |
Multikinase Inhibitor 4SC-203
A multikinase inhibitor with potential antineoplastic activity. Multikinase inhibitor 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs). This may result in the inhibition of angiogenesis and cell proliferation in tumor cells in which these kinases are upregulated. FLT3 (FLK2), a class III tyrosine kinase receptor, is overexpressed or mutated in most B lineage and acute myeloid leukemias (AML). VEGFRs, tyrosine kinase receptors, are overexpressed in a variety of tumor cell types and play key roles in angiogenesis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used in MRI to help make clear pictures of blood vessels in the brain, spine, and nearby tissues. It is…
A laboratory test in which many genes are studied in a sample of tissue. Multigene tests may help find mutations (changes) in…
An orally available, multivalent herbal formulation containing a novel mixture of whole extracts from three commonly used Chinese medicinal herbs Ganoderma lucidum…
The innermost layer of the cerebral cortex. It consists of numerous small neurons, small pyramidal cells, stellate cells, especially superficially and fusiform…
An electrocardiographic finding of premature ventricular complexes which have two or more distinct morphologies, suggesting origin at more than one ventricular…
A primary bone osteosarcoma affecting multiple bone sites.
